Our results indicate that inhibition of TRPM4 expression could significantly reduce hippocampal neuron apoptosis and improve neurocognitive function in PND rats. We observed that pre-modeling TRPM4 inhibition reduced neuroapoptosis in the hippocampus and improved learning and memory function in this rat model, consistent with what Charlene P. Poore reported (Poore, CP, Hazalin, NAMN, Wei, S, et al).
Transient receptor potential melastatin 4 is a member of the TRPM protein family, is sensitive to Ca2+, only penetrates monovalent cations, is an impermeable bivalent cation, is expressed in many organs, through adjusting the membrane potential changes, and is able to participate in a variety of pathological processes. Physiologically, TRPM 4 is mainly related to cardiac physiology and vascular tone regulation in the circulatory system, kidney physiology in the urinary system, nervous system and neuronal activity, various neurohumoral regulation, and immunity. "It is pathologically associated with arrhythmia, myocardial ischemia-reperfusion injury, stroke, cerebral ischemia-reperfusion injury, subarachnoid hemorrhage, and cancer of some organs." The results of many existing studies show the potential of TRPM4 inhibition for the treatment of patients with various central nervous system disorders. TRPM4 may also become a therapeutic entry point for other system-related diseases in the future. 9-phenanthol, a specific inhibitor of transient receptor potential melastatin (TRPM) 4 channel, can regulate a variety of physiological processes through TRPM4 current inhibition, thereby exerting beneficial effects in a variety of pathological conditions. 9 - PH inhibits TRPM4 expression, and reduces apoptosis-related molecules and inflammatory cytokines, such as the expression of BAX and IL-6. (Ma, P, Huang, N, Tang, J, et al. ) Inhibition of TRPM4 has a protective effect on Chronic cerebral hypoperfusion (Hazalin, NAMN, et al. 2020). TRPM4 contributes to the death of Mossy cells after status epilepticus (Mundrucz, L, et al. 2023). Inhibition of TRPM4 can reduce the apoptosis of neurons in the hippocampus. Improved learning and memory (Poore, CP, Hazalin, NAMN, Wei, S, et al.2024). Given the role of inhibition of TRPM4 in the treatment of various neurological diseases, we believe that inhibition of the TRPM4 pathway may have a beneficial effect on PND. Therefore, we investigated whether inhibition of TRPM4 improved cognitive dysfunction in a rat model of PND induced by tibial fracture reduction and internal fixation, and further explored the possible mechanisms. Our current study shows that surgery leads to cognitive dysfunction in older rats, resulting in increased apoptosis of hippocampal neurons. Inhibition of the TRPM4 pathway may significantly improve the cognitive function of rats by inhibiting the apoptosis of hippocampal neurons. Our results suggest that inhibition of the TRPM4 pathway has a significant brain protective effect in PND rats.
A new study finds that in the rat model with chronic hypoxia, TRPM4 treatment can reduce the blocking antibody M4P hippocampal neurons apoptosis, relieve long cheng enhanced damage, and improve the learning and memory function of the rat model. (Poore, CP, Hazalin, NAMN, Wei, S, et al.2024) The inhibitor of TRPM4, 9-PH, significantly reduced brain water content, blood-brain barrier disruption, neuronal apoptosis, and neurobehavioral deficits in a cerebral edema model. (Ma, P, Huang, N, Tang, J, et al.2023) Trpm4 deficiency in a mouse model of status epilepticus significantly attenuated neuronal loss, cell necrosis, and apoptosis, as well as astrocytosis and microgliosis in the hippocampus and piriform cortex. (Chen, X, Liu, K, Lin, Z, et al.,2020) We found that the expression of TRPM4 was increased in aged PND rats by WB, PCR, IF, and other experimental methods. Y-maze and novel object recognition experiments were used to explore the protective effect on cognitive function in aged PND rats.
Ulinastatin is a serine protease inhibitor, which exists in human blood and urine. It has a strong inhibitory effect on a variety of serine proteases such as trypsin and thrombin. Ulinastatin can inhibit inflammation, restrain apoptosis, improve immune function, and protect tissues and organs. It has been used to treat pancreatitis, sepsis, and so on. In addition, recent studies have shown that ulinastatin can significantly reduce the occurrence of POCD in elderly patients after general anesthesia, inhibit the inflammatory response, and reduce cell and tissue damage. []Ulinastatin can prevent general anesthesia before giving ulinastatin can prevent neuronal damage and cognitive decline after general anesthesia. The protective effect of ulinastatin was associated with the inhibition of microglial activation. Its target in the activation of microglia is the M1 phenotype. (Cho, EH, In, CB, Lee, GW, et al., 2024), our research found that preoperative giving ulinastatin can inhibit TRPM4 expression, and protect elderly PND unit cognitive function in rats.
Clinically, PND mainly occurs in elderly patients, and age is an independent risk factor. In addition, some studies have shown that inhaled general anesthesia is also a risk factor for PND. To better simulate clinical situations, in this study, we use inhaled general anesthesia and orthopedic surgery in the senile rats PND unit model was set up, and we found that the general anesthesia and surgery cause cognitive impairment in the elderly rats, inhibit TRPM4 significantly improve the cognitive behavior of PND.
To sum up, ulinastatin can inhibit the TRPM4 pathway, improve operation caused by cognitive dysfunction, inhibition of hippocampal neuron apoptosis. TRPM4 may be an effective prevention of PND unit targets.